Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance

Charles River Laboratories Intl. IncTrade
Schwab US Dividend Equity ETFTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Schwab US Dividend Equity ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Schwab US Dividend Equity ETF trades at $34.27. Which is the better fit depends on your goals.

CRLSCHD
Market Cap
$13.46B
Sector
HealthBroad Market / Factor
52-Week High
$282.00$34.27
52-Week Low
$145.57$26.44
Enterprise Value
$16.30B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD